TR200000697T2 - İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. - Google Patents

İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.

Info

Publication number
TR200000697T2
TR200000697T2 TR2000/00697T TR200000697T TR200000697T2 TR 200000697 T2 TR200000697 T2 TR 200000697T2 TR 2000/00697 T TR2000/00697 T TR 2000/00697T TR 200000697 T TR200000697 T TR 200000697T TR 200000697 T2 TR200000697 T2 TR 200000697T2
Authority
TR
Turkey
Prior art keywords
benzazosin
methano
ols
hexahydro
substituted
Prior art date
Application number
TR2000/00697T
Other languages
English (en)
Inventor
Grauert Matthias
Carter Adrian
Bechtel Wolf-Dietrich
Weiser Thomas
Palluk Rainer
Pschorn Uwe
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200000697T2 publication Critical patent/TR200000697T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Eldeki bulus genel formül (I)'in yeni, ikame edilmis 1, 2, 3, 4, 5, 6-heksahidro-2, 6-metano-3-benzazosin-10-ol'larini, üretim yöntemlerini ve farmasötik preparat olarak kullanimlarini kapsamaktadir.(Formül(I)).
TR2000/00697T 1997-09-12 1998-09-09 İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. TR200000697T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19740110A DE19740110A1 (de) 1997-09-12 1997-09-12 Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
TR200000697T2 true TR200000697T2 (tr) 2001-01-22

Family

ID=7842134

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00697T TR200000697T2 (tr) 1997-09-12 1998-09-09 İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.

Country Status (38)

Country Link
US (1) US6455538B1 (tr)
EP (1) EP1015433B1 (tr)
JP (1) JP3827528B2 (tr)
KR (1) KR100601008B1 (tr)
CN (1) CN1166640C (tr)
AR (1) AR017095A1 (tr)
AT (1) ATE267811T1 (tr)
AU (1) AU751036B2 (tr)
BG (1) BG64418B1 (tr)
BR (1) BR9812443A (tr)
CA (1) CA2302347C (tr)
CO (1) CO5011117A1 (tr)
CZ (1) CZ296909B6 (tr)
DE (2) DE19740110A1 (tr)
DK (1) DK1015433T3 (tr)
EE (1) EE04398B1 (tr)
ES (1) ES2222612T3 (tr)
HR (1) HRP980502B1 (tr)
HU (1) HUP0004588A3 (tr)
ID (1) ID24173A (tr)
IL (1) IL134572A (tr)
MY (1) MY120550A (tr)
NO (1) NO315650B1 (tr)
NZ (1) NZ503710A (tr)
PE (1) PE122899A1 (tr)
PL (1) PL198486B1 (tr)
PT (1) PT1015433E (tr)
RS (1) RS49888B (tr)
RU (1) RU2218334C2 (tr)
SA (1) SA98190765B1 (tr)
SK (1) SK284670B6 (tr)
TR (1) TR200000697T2 (tr)
TW (1) TW505645B (tr)
UA (1) UA61973C2 (tr)
UY (2) UY25175A1 (tr)
WO (1) WO1999014199A1 (tr)
YU (1) YU12000A (tr)
ZA (1) ZA988285B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US6828311B2 (en) 2002-05-29 2004-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation for the parenteral application of a sodium channel blocker
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
US20030235576A1 (en) * 2002-06-15 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of ischaemic conditions
DE10226814A1 (de) * 2002-06-15 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
AU2006329040C1 (en) 2005-12-22 2011-12-08 Newron Pharmaceuticals S.P.A. 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators
CN101687773B (zh) 2007-06-15 2014-07-30 纽朗制药有限公司 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用
ME02524B (me) 2011-06-27 2017-02-20 Newron Pharm Spa Fluorisani derivati arilalkilaminokarboksamida

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828039A1 (de) 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
US4208523A (en) * 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE4121821A1 (de) 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
DK1015433T3 (da) 2004-09-27
PL198486B1 (pl) 2008-06-30
RS49888B (sr) 2008-08-07
RU2218334C2 (ru) 2003-12-10
KR100601008B1 (ko) 2006-07-19
EE200000129A (et) 2001-02-15
NO20001288L (no) 2000-03-13
ZA988285B (en) 1999-03-12
CA2302347C (en) 2008-06-17
NO20001288D0 (no) 2000-03-10
PT1015433E (pt) 2004-08-31
AU751036B2 (en) 2002-08-08
JP3827528B2 (ja) 2006-09-27
YU12000A (sh) 2002-11-15
EP1015433A1 (de) 2000-07-05
BG104232A (en) 2000-10-31
JP2001516747A (ja) 2001-10-02
CN1269790A (zh) 2000-10-11
HRP980502A2 (en) 1999-06-30
UY25439A1 (es) 1999-11-17
HRP980502B1 (en) 2005-02-28
SA98190765B1 (ar) 2006-06-10
PE122899A1 (es) 1999-12-06
PL339061A1 (en) 2000-12-04
HUP0004588A3 (en) 2002-10-28
UY25175A1 (es) 2000-12-29
CA2302347A1 (en) 1999-03-25
NZ503710A (en) 2002-04-26
WO1999014199A1 (de) 1999-03-25
AU9624298A (en) 1999-04-05
CO5011117A1 (es) 2001-02-28
EP1015433B1 (de) 2004-05-26
CZ2000894A3 (cs) 2000-09-13
BG64418B1 (bg) 2005-01-31
US6455538B1 (en) 2002-09-24
SK284670B6 (sk) 2005-08-04
IL134572A0 (en) 2001-04-30
CN1166640C (zh) 2004-09-15
EE04398B1 (et) 2004-12-15
AR017095A1 (es) 2001-08-22
MY120550A (en) 2005-11-30
KR20010023879A (ko) 2001-03-26
BR9812443A (pt) 2000-09-26
CZ296909B6 (cs) 2006-07-12
ID24173A (id) 2000-07-13
HUP0004588A2 (hu) 2001-07-30
ATE267811T1 (de) 2004-06-15
NO315650B1 (no) 2003-10-06
DE59811477D1 (de) 2004-07-01
UA61973C2 (en) 2003-12-15
ES2222612T3 (es) 2005-02-01
TW505645B (en) 2002-10-11
IL134572A (en) 2005-05-17
DE19740110A1 (de) 1999-03-18
SK3342000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
TR199901653T2 (tr) Fitalazinonlar.
CO5210911A1 (es) Trifluorbutenos nematicidas
NO970042D0 (no) 2-£(Dihydro)pyrazolyl-3'-oksymetylen|-anilider, fremgangsmåte til fremstilling og anvendelse derav
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
TR199901305T2 (tr) Calpain-önleyicileri olarak ketonbenzamidler
SE9504661D0 (sv) New compounds
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
NO954320L (no) Lyosfærer omfattende gonadotropin
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
TR199801328T2 (tr) Yeni tarz benzoilguanidin-türevleri, üretim yöntemleri.
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69614149T2 (de) Chinolinderivate als antimalariamittel
ATE297903T1 (de) Substituierte phenyluracile
DE69128473D1 (de) An sigma-bindungsstellen wirkende stoffe
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
SE9402880D0 (sv) New peptide derivatives
DK1204659T3 (da) Serotonerge benzofuraner
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
TR199701202T1 (tr) Yeni hidroksimik asit türevleri.
SE9504662D0 (sv) New compounds
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona